Literature DB >> 10984605

PDGF-induced Akt phosphorylation does not activate NF-kappa B in human vascular smooth muscle cells and fibroblasts.

B H Rauch1, A Weber, M Braun, N Zimmermann, K Schrör.   

Abstract

A recent report suggested that platelet-derived growth factor (PDGF) activates nuclear factor-kappa B (NF-kappa B) by phosphorylation of the protein kinase Akt [Romashkova and Makarov, Nature 401 (1999) 86-90]. The present study investigates the role of Akt in the activation of NF-kappa B by tumor necrosis factor-alpha (TNF alpha, 10 ng/ml) and PDGF-BB (20 ng/ml) in human vascular smooth muscle cells (SMC), skin and foreskin fibroblasts. TNF alpha stimulated serine phosphorylation and degradation of the inhibitory protein I kappa B alpha and strongly induced nuclear NF-kappa B translocation and binding activity. PDGF did not induce serine phosphorylation or degradation of I kappa B alpha and did not enhance binding activity of NF-kappa B. In contrast, stimulation with PDGF resulted in a marked phosphorylation of Akt, but no Akt phosphorylation occurred after stimulation with TNF alpha. These data suggest that Akt phosphorylation is not involved in NF-kappa B activation in human SMC and fibroblasts.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10984605     DOI: 10.1016/s0014-5793(00)01957-8

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  12 in total

1.  ETV6-PDGFRB and FIP1L1-PDGFRA stimulate human hematopoietic progenitor cell proliferation and differentiation into eosinophils: the role of nuclear factor-κB.

Authors:  Carmen P Montano-Almendras; Ahmed Essaghir; Hélène Schoemans; Inci Varis; Laura A Noël; Amélie I Velghe; Dominique Latinne; Laurent Knoops; Jean-Baptiste Demoulin
Journal:  Haematologica       Date:  2012-01-22       Impact factor: 9.941

2.  Activation of NF-kappaB is essential for hepatocyte growth factor-mediated proliferation and tubulogenesis.

Authors:  Markus Müller; Alessandro Morotti; Carola Ponzetto
Journal:  Mol Cell Biol       Date:  2002-02       Impact factor: 4.272

Review 3.  Carcinogenic metals and NF-kappaB activation.

Authors:  F Chen; M Ding; V Castranova; X Shi
Journal:  Mol Cell Biochem       Date:  2001-06       Impact factor: 3.396

4.  NF-kappaB controls growth of glioblastomas/astrocytomas.

Authors:  Denise Smith; Takeshi Shimamura; Stephanie Barbera; Bruce E Bejcek
Journal:  Mol Cell Biochem       Date:  2007-09-09       Impact factor: 3.396

5.  Uromodulin p.Cys147Trp mutation drives kidney disease by activating ER stress and apoptosis.

Authors:  Bryce G Johnson; Lan T Dang; Graham Marsh; Allie M Roach; Zebulon G Levine; Anthony Monti; Deepak Reyon; Lionel Feigenbaum; Jeremy S Duffield
Journal:  J Clin Invest       Date:  2017-10-09       Impact factor: 14.808

6.  Tumor necrosis factor-alpha promotes survival of opossum kidney cells via Cdc42-induced phospholipase C-gamma1 activation and actin filament redistribution.

Authors:  Evangelia A Papakonstanti; Christos Stournaras
Journal:  Mol Biol Cell       Date:  2003-12-29       Impact factor: 4.138

7.  Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women.

Authors:  Mihoko Yoshino; Jun Yoshino; Brandon D Kayser; Gary J Patti; Michael P Franczyk; Kathryn F Mills; Miriam Sindelar; Terri Pietka; Bruce W Patterson; Shin-Ichiro Imai; Samuel Klein
Journal:  Science       Date:  2021-04-22       Impact factor: 47.728

8.  Activation of nuclear factor kappaB and Bcl-x survival gene expression by nerve growth factor requires tyrosine phosphorylation of IkappaBalpha.

Authors:  N T Bui; A Livolsi; J F Peyron; J H Prehn
Journal:  J Cell Biol       Date:  2001-02-19       Impact factor: 10.539

Review 9.  Akt in the pathogenesis of COPD.

Authors:  Steven Bozinovski; Ross Vlahos; Michelle Hansen; Ken Liu; Gary P Anderson
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2006

10.  Influence of pentylenetetrazol and NF-κB decoy oligodeoxynucleotides on p38 expression in neuron-like cells.

Authors:  Jia-Jun Yang; Wei-Hua Li; Bang-Jian Liu; Rong-Hua Tang; Yu-Hong Zhang
Journal:  Exp Ther Med       Date:  2014-06-10       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.